Journal of Healthcare Engineering

Journal of Healthcare Engineering / 2014 / Article

Research Article | Open Access

Volume 5 |Article ID 391407 | https://doi.org/10.1260/2040-2295.5.4.393

Weizeng Ni, Samuel H. Huang, Qiang Su, Jinghua Shi, "Model-Independent Evaluation of Tumor Markers and a Logistic-Tree Approach to Diagnostic Decision Support", Journal of Healthcare Engineering, vol. 5, Article ID 391407, 18 pages, 2014. https://doi.org/10.1260/2040-2295.5.4.393

Model-Independent Evaluation of Tumor Markers and a Logistic-Tree Approach to Diagnostic Decision Support

Abstract

Sensitivity and specificity of using individual tumor markers hardly meet the clinical requirement. This challenge gave rise to many efforts, e.g., combing multiple tumor markers and employing machine learning algorithms. However, results from different studies are often inconsistent, which are partially attributed to the use of different evaluation criteria. Also, the wide use of model-dependent validation leads to high possibility of data overfitting when complex models are used for diagnosis. We propose two model-independent criteria, namely, area under the curve (AUC) and Relief to evaluate the diagnostic values of individual and multiple tumor markers, respectively. For diagnostic decision support, we propose the use of logistic-tree which combines decision tree and logistic regression. Application on a colorectal cancer dataset shows that the proposed evaluation criteria produce results that are consistent with current knowledge. Furthermore, the simple and highly interpretable logistic-tree has diagnostic performance that is competitive with other complex models.

References

  1. H. Özkan, M. Kaya, and A. Cengiz, “Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer,” Hepato-Gastroenterology, vol. 50, pp. 1669–1674, 2003. View at: Google Scholar
  2. M. Moghimi and I. Ghodosi, “Clinical efficacy of combined use of CEA-CA19-9 in patients with pancreatic malignancy,” Journal of Medical Sciences, vol. 7, pp. 625–629, 2007. View at: Google Scholar
  3. X. G. Ni, X. F. Bai, Y. L. Mao, Y. F. Shao, J. X. Wu, Y. Shan et al., “The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer,” European Journal of Surgical Oncology, vol. 31, pp. 164–169, 2005. View at: Google Scholar
  4. Z. Sun, X. Fu, L. Zhang, X. Yang, F. Liu, and G. Hu, “A Protein Chip System for Parallel Analysis of Multi-tumor Markers and its Application in Cancer Detection,” Anticancer Research, vol. 24, pp. 1159–1165, 2004. View at: Google Scholar
  5. L. M. McShane, D. G. Altman, W. Sauerbrei, S. E. Taube, M. Gion, and G. M. Clark, “Reporting recommendations for tumor marker prognostic studies,” Journal of Clinical Oncology, vol. 23, pp. 9067–9072, 2005. View at: Google Scholar
  6. D. Marrelli, S. Caruso, A. Neri, C. Pedrazzani, L. Capuano, M. A. Mazzei et al., “Clinical utility of serum tumor markers in the diagnosis of malignant intestinal occlusion. A prospective observational study,” International Journal of Biological Markers, vol. 26, pp. 58–64, 2011. View at: Google Scholar
  7. X. L. Qin, Z. R. Wang, J. S. Shi, M. Lu, L. Wang, and Q. R. He, “Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA,” World Journal of Gastroenterology, vol. 10, pp. 427–432, 2004. View at: Google Scholar
  8. M. Carpelan-Holmström, J. Louhimo, U. H. Stenman, H. Alfthan, H. Järvinen, and C. Haglund, “Estimating the probability of cancer with several tumor markers in patients with colorectal disease,” Oncology, vol. 66, pp. 296–302, 2004. View at: Google Scholar
  9. T. C. W. Poon, A. T. C. Chan, B. Zee, S. K. W. Ho, T. S. K. Mok, T. W. T. Leung et al., “Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma,” Oncology, vol. 61, pp. 275–283, 2001. View at: Google Scholar
  10. H. J. Song, Y. S. Kim, K. W. Choi, J. D. Kim, C. Y. Park, E. Lee et al., “Building Biomarker Combinations for Korean Ovarian Cancer Screening Using Statistics and Machine Learning,” Applied Mechanics and Materials, vol. 145, pp. 229–233, 2012. View at: Google Scholar
  11. S. M. Winkler, M. Affenzeller, W. Jacak, and H. Stekel, “Identification of cancer diagnosis estimation models using evolutionary algorithms: a case study for breast cancer, melanoma, and cancer in the respiratory system,” in Proceedings of the 13th annual conference companion on Genetic and evolutionary computation, pp. 503–510, ACM, 2011. View at: Google Scholar
  12. Winkler*, S. M., Affenzeller, M., Kronberger, G., Kommenda, M., Wagner, S., Dorfer, V. et al. “On the use of estimated tumour marker classifications in tumour diagnosis prediction-a case study for breast cancer,” International Journal of Simulation and Process Modelling. 2013, 8:29-41.
  13. L. Bottaci, P. J. Drew, J. E. Hartley, M. B. Hadfield, R. Farouk, P. W. R. Lee et al., “Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions,” Lancet, vol. 350, pp. 469–472, 1997. View at: Google Scholar
  14. R. N. G. Naguib, M. C. Robinson, D. E. Neal, and F. C. Hamdy, “Neural network analysis of combined conventional and experimental prognostic markers in prostate cancer: A pilot study,” British Journal of Cancer, vol. 78, pp. 246–250, 1998. View at: Google Scholar
  15. Y. Wu, Y. Wu, J. Wang, Z. Yan, L. Qu, B. Xiang et al., “An optimal tumor marker group-coupled artificial neural network for diagnosis of lung cancer,” Expert Systems with Applications, vol. 38, pp. 11329–11334, 2011. View at: Google Scholar
  16. J. Flores, E. Herrera, G. Leal, M. González, F. Sánchez, A. Rojas et al., “Artificial neural network-based serum biomarkers analysis improves sensitivity in the diagnosis of lung cancer,” in V Latin American Congress on Biomedical Engineering CLAIB 2011, pp. 882–885, Springer, Habana, Cuba, May 16-21, 2011. View at: Google Scholar
  17. J. M. Flores-Fernández, E. J. Herrera-López, F. Sánchez-Llamas, A. Rojas-Calvillo, P. A. Cabrera-Galeana, G. Leal-Pacheco et al., “Development of an optimized multi-biomarker panel for the detection of lung cancer based on principal component analysis and artificial neural network modeling,” Expert Systems with Applications, vol. 39, pp. 10851–10856, 2012. View at: Google Scholar
  18. T. Casas Pina, I. Tovar Zapata, J. Bermejo López, J. Latour Pérez, P. P. Paricio, and P. Martínez Hernández, “Tumor markers in lung cancer: Does the method of obtaining the cut-off point and reference population influence diagnostic yield?” Clinical Biochemistry, vol. 32, pp. 467–472, 1999. View at: Google Scholar
  19. H. Körner, K. Söreide, P. J. Stokkeland, and J. A. Söreide, “Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: A receiver operating characteristic curve analysis,” Annals of Surgical Oncology, vol. 14, pp. 417–423, 2007. View at: Google Scholar
  20. H. L. Weiss, S. Niwas, W. E. Grizzle, and C. Piyathilake, “Receiver operating characteristic (ROC) to determine cut-off points of biomarkers in lung cancer patients,” Disease Markers, vol. 19, pp. 273–278, 2003. View at: Google Scholar
  21. H.-J. Song, J.-K. Yim, C.-Y. Park, Y.-S. Kim, and J.-D. Kim, “Comparison of the Diagnostic Performances of CA125 and Multiple Marker Combinations for Early Diagnosis of Ovarian Cancer,” International Journal of Bio-Science & Bio-Technology, vol. 5, 2013. View at: Google Scholar
  22. K. Kira and L. A. Rendell, “A Practical Approach to Feature Selection,” in Proceedings of the Ninth International Workshop on Machine Learning, pp. 249–256, Morgan Kaufmann Publishers Inc, 1992. View at: Google Scholar
  23. M. Robnik-Šikonja and I. Kononenko, “Theoretical and Empirical Analysis of ReliefF and RReliefF,” Machine Learning, vol. 53, pp. 23–69, 2003. View at: Google Scholar
  24. J. Shi, Q. Su, C. Zhang, G. Huang, and Y. Zhu, “An intelligent decision support algorithm for diagnosis of colorectal cancer through serum tumor markers,” Computer Methods and Programs in Biomedicine, vol. 100, pp. 97–107, 2010. View at: Google Scholar
  25. R. C. Bast Jr., P. Ravdin, D. F. Hayes, S. Bates, H. Fritsche Jr., J. M. Jessup et al., “Update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology,” Journal of Clinical Oncology, vol. 19, pp. 1865–1878, 2000. View at: Google Scholar
  26. N. Calonge, D. B. Petitti, T. G. DeWitt, A. J. Dietrich, K. D. Gregory, R. Harris et al., “Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement,” Annals of Internal Medicine, vol. 149, pp. 627–637, 2008. View at: Google Scholar

Copyright © 2014 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views414
Downloads465
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.